Neurochemical Research

, Volume 33, Issue 5, pp 808–813 | Cite as

Relative Expression of mRNAS Coding for Glutaminase Isoforms in CNS Tissues and CNS Tumors

  • Monika Szeliga
  • Ewa Matyja
  • Marta Obara
  • Wiesława Grajkowska
  • Tomasz Czernicki
  • Jan Albrecht
Original Paper


Glutaminase (GA) in mammalian tissues occurs in three isoforms: LGA (liver-type), KGA (kidney-type) and GAC (a KGA variant). Our previous study showed that human malignant gliomas (WHO grades III and IV) lack expression of LGA mRNA but are enriched in GAC mRNA relative to KGA mRNA. Here we analyzed the expression of mRNAs coding for the three isoforms in the biopsy material derived from other central nervous system tumors of WHO grades I–III. Non-neoplastic resective epileptic surgery samples served as control, as did cultured rat astrocytes and neurons. The GAC mRNA/KGA mRNA expression ratio was as a rule higher in the neoplastic than in control tissues, irrespective of the cell type dominating in the tumor or tumor malignancy. LGA mRNA expression was relatively very low in cultured astrocytes, and very low to absent in astrocytoma pilocyticum, ependymoma and subependymal giant cell astrocytoma (SEGA), tumors of astrocytic origin. LGA mRNA expression was almost as high as that of KGA and GAC mRNA in cultured neurons and epileptic surgery samples which were enriched in neurons. LGA mRNA was also relatively high in ganglioglioma which contains a discernable proportion of neuronal cells, and in oligodendroglioma. The results show that low expression of LGA mRNA is a feature common to normal astrocytes and astroglia-derived tumor cells or ependymomas and can be considered as a cell-type, rather than a malignancy marker.


Astrocytes Neurons Human brain Brain tumors Liver-type glutaminase (LGA) Kidney-type glutaminase (KGA) GAC RT-PCR 


  1. 1.
    Martin M, Beauvoit B, Voisin PJ et al (1998) Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation. J Bioenerg Biomem 30:565–578CrossRefGoogle Scholar
  2. 2.
    Medina MA, Sanchez-Jimenez F, Márquez J et al (1992) Relevance of glutamine metabolism to tumor cell growth. Mol Cell Biochem 113:1–15PubMedCrossRefGoogle Scholar
  3. 3.
    Souba WW (1993) Glutamine and cancer. Ann Surg 218:715–728PubMedCrossRefGoogle Scholar
  4. 4.
    Elgadi KM, Meguid RA, Qian M et al (1999) Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics 1:51–62PubMedGoogle Scholar
  5. 5.
    Gómez-Fabre PM, Aledo JC, del Castillo-Olivares A et al (2000) Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase. Biochem J 345:365–375PubMedCrossRefGoogle Scholar
  6. 6.
    Curthoys NP, Watford M (1995) Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15:133–159PubMedCrossRefGoogle Scholar
  7. 7.
    Porter LD, Ibrahim H, Taylor L et al (2002) Complexity and species variation of the kidney-type glutaminase gene. Physiol Genomics 9:57–66Google Scholar
  8. 8.
    Matsuno T, Goto I (1992) Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma. Cancer Res 52:1192–1194PubMedGoogle Scholar
  9. 9.
    Aledo JC, Segura JA, Medina MA et al (1994) Phosphate-activated glutaminase expression during tumor development. FEBS Lett 341:39–42PubMedCrossRefGoogle Scholar
  10. 10.
    Turner A, McGivan JD (2003) Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. Biochem J 370:403–408PubMedCrossRefGoogle Scholar
  11. 11.
    Pérez-Gómez C, Campos-Sandoval JA, Alonso FJ et al (2005) Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem J 386:535–542PubMedCrossRefGoogle Scholar
  12. 12.
    Lobo C, Ruiz-Bellido MA, Aledo JC et al (2000) Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem J 348:257–261PubMedCrossRefGoogle Scholar
  13. 13.
    Szeliga M, Sidoryk M, Matyja E et al (2005) Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas. Neurosci Lett 374:171–173PubMedCrossRefGoogle Scholar
  14. 14.
    Olalla L, Gutiérrez A, Campos JA et al (2002) Nuclear localization of L-glutaminase in mammalian brain. J Biol Chem 277:38939–38944PubMedCrossRefGoogle Scholar
  15. 15.
    Marquez J, de la Oliva AR, Matés JM et al (2006) Glutaminase: a multifaceted protein not only involved in generating glutamate. Neurochem Int 48: 465–471PubMedGoogle Scholar
  16. 16.
    Hertz L, Juurlink BHJ, Hertz E et al (1989) Preparation of primary cultures of mouse (rat) astrocytes. In: Shahar A, DeVellis J, Vernadakis A, Haber B (eds) A dissection and tissue culture manual for the nervous system, Alan R. Liss, New York, pp 105–108Google Scholar
  17. 17.
    Hertz E, Yu ACH, Hertz L, Juurlink BHJ, Schousboe A (1989) Preparation of primary cultures of mouse cortical neurons. In: Shahar A, De Vellis J, Vernadakis A, Haber B (eds) A dissection and tissue culture manual for the nervous system, Alan R Liss, New York, pp 183–186Google Scholar
  18. 18.
    Kvamme E, Torgner IA, Roberg, B (2001) Kinetics and localization of brain phosphate activated glutaminase. J Neurosci Res 66:951–958PubMedCrossRefGoogle Scholar
  19. 19.
    Laake JH, Takumi, Y, Eidet, J et al (1999) Postembedding immunogold labelling reveals subcellular localization and pathway-specific enrichment of phosphate activated glutaminase in rat cerebellum. Neuroscience 88:1137–1151PubMedCrossRefGoogle Scholar
  20. 20.
    Hogstad S, Svenneby, G, Torgner, IA et al (1988) Glutaminase in neurons and astrocytes cultured from mouse brain: kinetic properties and effects of phosphate, glutamate, and ammonia. Neurochem Res 13:383–8PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Monika Szeliga
    • 1
  • Ewa Matyja
    • 2
  • Marta Obara
    • 1
  • Wiesława Grajkowska
    • 3
  • Tomasz Czernicki
    • 4
  • Jan Albrecht
    • 1
  1. 1.Department of Neurotoxicology, M. Mossakowski Medical Research CenterPolish Academy of SciencesWarsawPoland
  2. 2.Department of Experimental and Clinical Neuropathology, M. Mossakowski Medical Research CenterPolish Academy of SciencesWarsawPoland
  3. 3.Department of PathologyChildren’s Memorial Health InstituteWarsawPoland
  4. 4.Department of NeurosurgeryMedical University of WarsawWarsawPoland

Personalised recommendations